Sucampo Pharma (SCMP) Tops Q4 EPS by 24c

Sucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.43, $0.24 better than the analyst estimate of $0.19. Revenue for the quarter came in at $55.4 million versus the consensus estimate of $42.72 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c